Hema Viswanathan1, Rodney Anderson, Joseph Thomas. 1. School of Pharmacy and Pharmacal Sciences, Department of Pharmacy Practice, Purdue University, West Lafayette, IN 47907-2091, USA.
Abstract
OBJECTIVES: This study describes health-related quality of life (HRQOL) among low-income HIV adults using an HIV service center, compares participants' scores to US published norms for the general population and persons with chronic conditions, and examines relationships between patient characteristics, nonadherence, and HRQOL. METHODS: A cross-sectional survey of individuals on antiretroviral therapy was conducted. The Medical Outcomes Study SF-12 was used to assess HRQOL. Medication nonadherence was assessed using the 9-item Morisky Adherence Scale. Data also were collected on social support, CD4 cell count, and time since diagnosis. RESULTS: Approximately 84% of the 86 participants were male, 50% were white, and 39% were black. The mean +/- SD Physical component summary (PCS-12) score of 41.0 +/- 12.5 and Mental component summary (MCS-12) score of 41.9 +/- 11.0 were lower than US general population norms (p < 0.001). PCS-12 scores were similar to those of patients with other chronic conditions. Respondents reported lower MCS-12 scores than patients with hypertension and diabetes (p < 0.006). Employment and higher social support had positive associations with PCS-12 scores and nonadherence had a negative association with MCS-12 scores (p < 0.05). CONCLUSIONS: HRQOL in this sample of low-income HIV adults was comparable to other HIV populations. Identifying strategies for increasing social support and medication adherence for economically disadvantaged persons with HIV/ AIDS may improve their HRQOL.
OBJECTIVES: This study describes health-related quality of life (HRQOL) among low-income HIV adults using an HIV service center, compares participants' scores to US published norms for the general population and persons with chronic conditions, and examines relationships between patient characteristics, nonadherence, and HRQOL. METHODS: A cross-sectional survey of individuals on antiretroviral therapy was conducted. The Medical Outcomes Study SF-12 was used to assess HRQOL. Medication nonadherence was assessed using the 9-item Morisky Adherence Scale. Data also were collected on social support, CD4 cell count, and time since diagnosis. RESULTS: Approximately 84% of the 86 participants were male, 50% were white, and 39% were black. The mean +/- SD Physical component summary (PCS-12) score of 41.0 +/- 12.5 and Mental component summary (MCS-12) score of 41.9 +/- 11.0 were lower than US general population norms (p < 0.001). PCS-12 scores were similar to those of patients with other chronic conditions. Respondents reported lower MCS-12 scores than patients with hypertension and diabetes (p < 0.006). Employment and higher social support had positive associations with PCS-12 scores and nonadherence had a negative association with MCS-12 scores (p < 0.05). CONCLUSIONS: HRQOL in this sample of low-income HIV adults was comparable to other HIV populations. Identifying strategies for increasing social support and medication adherence for economically disadvantaged persons with HIV/ AIDS may improve their HRQOL.
Authors: A W Wu; H R Rubin; W C Mathews; J E Ware; L T Brysk; W D Hardy; S A Bozzette; S A Spector; D D Richman Journal: Med Care Date: 1991-08 Impact factor: 2.983
Authors: Mehri S McKellar; Maragatha N Kuchibhatla; Kris Ann K Oursler; Stephen Crystal; Kathleen M Akgün; Kristina Crothers; Cynthia L Gibert; Karen Nieves-Lugo; Julie Womack; Janet P Tate; Gerda G Fillenbaum Journal: AIDS Res Hum Retroviruses Date: 2019-06-18 Impact factor: 2.205
Authors: Alexander C Tsai; Sheri D Weiser; Samantha E Dilworth; Martha Shumway; Elise D Riley Journal: Am J Epidemiol Date: 2015-03-31 Impact factor: 4.897
Authors: Björn Södergård; Margit Halvarsson; Stefan Lindbäck; Anders Sönnerborg; Mary P Tully; Asa Kettis Lindblad Journal: Pharm World Sci Date: 2006-10-26
Authors: Darren J Clayson; Diane J Wild; Paul Quarterman; Isabelle Duprat-Lomon; Maria Kubin; Stephen Joel Coons Journal: Pharmacoeconomics Date: 2006 Impact factor: 4.981
Authors: Omary Ubuguyu; Olivia C Tran; Robert Douglas Bruce; Frank Masao; Cassian Nyandindi; Norman Sabuni; Sheryl McCurdy; Jessie Mbwambo; Barrot H Lambdin Journal: Int J Drug Policy Date: 2016-03-11
Authors: P Todd Korthuis; Mary Jo Tozzi; Vijay Nandi; David A Fiellin; Linda Weiss; James E Egan; Michael Botsko; Angela Acosta; Marc N Gourevitch; David Hersh; Jeffrey Hsu; Joshua Boverman; Frederick L Altice Journal: J Acquir Immune Defic Syndr Date: 2011-03-01 Impact factor: 3.731
Authors: Karen Nieves-Lugo; Ana Maria Del Rio-Gonzalez; Carol Reisen; Paul Poppen; Krisann K Oursler; Maria Cecilia Zea Journal: J Int Assoc Provid AIDS Care Date: 2016-07-08
Authors: Alexander Y Walley; Debbie M Cheng; Howard Libman; David Nunes; C Robert Horsburgh; Richard Saitz; Jeffrey H Samet Journal: AIDS Date: 2008-01-30 Impact factor: 4.177